معرفی
Dr. Stuart McCracken is a researcher affiliated with Newcastle University, focusing on prostate cancer biology and molecular mechanisms. His work spans diagnostic innovation, therapeutic target identification, and clinical outcomes assessment.
- Prostate cancer diagnostics and treatment evaluation
- Androgen receptor signaling pathways
- Ubiquitin and kinase regulatory networks
- CRISPR-based genomic studies
- Clinical-translation research
Dr. McCracken’s research explores prostate cancer progression through molecular profiling and signaling pathway analysis. Key areas include:
- Androgen receptor regulation (via methylation, deubiquitination, and kinase interactions)
- Target identification in pathways like Hippo, MEK5/ERK5, and PI3K/AKT
- Clinical decision tools (e.g., MRI-based nomograms)
- Surgical outcome analysis (focal cryotherapy vs. radical prostatectomy)
His recent publications (2020–2023) emphasize CRISPR-engineered models, PARP inhibitor sensitivities, and novel anti-androgen therapies. Earlier work (2005–2011) laid groundwork in growth factor signaling and protein regulation mechanisms.
۰مقاله منتشرشده